Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

Cancer treatment has come a long way since the days of just chemotherapy. Today, many people are hearing about targeted therapy and immunotherapy, which are smarter, more precise ways to treat cancer.

Targeted therapy is a form of precision medicine. We’ve been moving away over the last 10-15 years from conventional chemotherapy, which can be effective against certain cancers. But it carries lots ...

In laboratory and animal models, the combination triggered greater cancer cell death and slowed tumor growth compared with either therapy alone, suggesting a potential new approach for developing the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted cancer drug offers a superior first-line treatment for aggressive ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A groundbreaking new antibody-drug conjugate offers hope for women with recurrent or ...

In the randomized phase 2b VIRAGE trial, patients with treatment-naive metastatic pancreatic cancer received the hyaluronidase-expressing oncolytic adenovirus zabilugene almadenorepvec (VCN-01) ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Precision oncology, ADC innovation and radiopharmaceutical acquisitions drive growth, while strong U.S. approvals and hospital demand reinforce expansionDublin, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ...